Biosynex Liabilities 2025

Biosynex Aktienanalyse

What does Biosynex do?

The company Biosynex SA was founded in 2005 in Strasbourg, France. The company is a manufacturer and distributor of diagnostic test kits used for the rapid and accurate diagnosis of various infectious diseases and other health conditions. Biosynex SA has established itself as a leading player in the global health market in recent years. The business model of Biosynex SA includes the design, manufacture, and distribution of various medical diagnostic tests that are capable of quickly and efficiently detecting pathogens and other health conditions. The company offers a wide range of medical test kits that can be used for the diagnosis of HIV/AIDS, hepatitis C, syphilis, rapid pregnancy tests, menopause, bleeding during pregnancy, vitamin D deficiency, and many other health conditions. The main focus of Biosynex SA is on developing test kits that are easy to use and provide accurate and reliable results. With its technological know-how and collaboration with leading experts in the field of medical diagnostics, Biosynex SA has taken a leading position in the development and marketing of medical diagnostic test kits. By collaborating with doctors, hospitals, and clinics globally, Biosynex SA has successfully expanded its business. Biosynex SA has various business areas specifically focused on the marketing and distribution of medical diagnostic tests. The most well-known areas include gynecology, infectious diseases, and pediatrics. Biosynex SA also has a strong presence in the global market, including Asia, Europe, Africa, and America. One of the most well-known products of Biosynex SA is the HIV self-test called Autotest VIH®, which is available in many European countries and North America. The test kit is CE marked and approved by leading health authorities such as the WHO and the EU. The product is an important tool in reducing the spread of HIV infections and allowing people to make a confidential diagnosis of HIV/AIDS in a private setting. In the field of gynecology, Biosynex SA offers various products such as the Unistick® pregnancy test, Unistick® ovulation test, and Unistick® menopause test kit. These products enable women to easily and efficiently diagnose pregnancy, ovulation, and menopause. The test kits are easy to use, can be used at home, and provide results within minutes. In summary, Biosynex SA has earned its leading position in the global market due to its focus on innovative technology and high-quality product range. The company has made a significant contribution to improving healthcare worldwide with its expertise and commitment to diagnosing health conditions. Biosynex SA will continue to expand its business in the future to support even more people worldwide and further improve the quality of healthcare. Biosynex ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Biosynex's Liabilities

Biosynex's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Biosynex's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Biosynex's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Biosynex's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Biosynex’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Biosynex stock

What is the level of liabilities of Biosynex this year?

Biosynex has a debt balance of 114.11 M EUR this year.

What were the liabilities of Biosynex compared to the previous year?

The liabilities of Biosynex have increased by -2.67% dropped compared to the previous year.

What are the consequences of high debt for investors of Biosynex?

High liabilities can pose a risk for investors of Biosynex, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Biosynex?

Low liabilities mean that Biosynex has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Biosynex affect the company?

An increase in liabilities of Biosynex can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Biosynex affect the company?

A decrease in the liabilities of Biosynex can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Biosynex?

Some factors that can influence the liabilities of Biosynex include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Biosynex so important for investors?

The liabilities of Biosynex are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Biosynex take to modify the liabilities?

To change its liabilities, Biosynex can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Biosynex pay?

Over the past 12 months, Biosynex paid a dividend of 2 EUR . This corresponds to a dividend yield of about 155.04 %. For the coming 12 months, Biosynex is expected to pay a dividend of 0 EUR.

What is the dividend yield of Biosynex?

The current dividend yield of Biosynex is 155.04 %.

When does Biosynex pay dividends?

Biosynex pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biosynex?

Biosynex paid dividends every year for the past 1 years.

What is the dividend of Biosynex?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biosynex located?

Biosynex is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biosynex kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biosynex from 5/18/2022 amounting to 2 EUR, you needed to have the stock in your portfolio before the ex-date on 5/16/2022.

When did Biosynex pay the last dividend?

The last dividend was paid out on 5/18/2022.

What was the dividend of Biosynex in the year 2024?

In the year 2024, Biosynex distributed 0 EUR as dividends.

In which currency does Biosynex pay out the dividend?

The dividends of Biosynex are distributed in EUR.